We are pleased to share the news of our strategic collaboration with BIOTON S.A. Together, we embark on a groundbreaking proof-of-concept project aimed at transdermal insulin delivery – a pioneering initiative set to make history.

Bio Europe 2023 in Munich was a huge success for Biotts.

Join us at BioEurope 2023 in Munich!
We’re thrilled to extend a warm invitation to you for our exclusive presentation on November 6th at 3:30 pm.

At BIOTTS we are gearing up for this year’s CPHI Worldwide event happening in Barcelona. It’s a fantastic opportunity to present the new possibilities of our innovative transdermal delivery technology, capable of transporting large molecules such as proteins and peptides through the skin. We’re thrilled to be a part of it!

We are thrilled to unveil our brand-new website, showcasing the revolutionary Multifunctional Transdermal Carrier Y (MTC-Y™) technology developed by Biotts, a global leader in Transdermal Drug Delivery.

Our Biotts team – Dr. Paweł Biernat, CEO & Transdermal Systems Specialist, and Jan Hendriks, CBO, took part in the annual conference Advanced Technologies & Treatments for Diabetes (ATTD) 2023 in Berlin.